Related references
Note: Only part of the references are listed.Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities
Rolando Cannalire et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Genomic and proteomic mutation landscapes of SARS-CoV-2
Christian Luke D. C. Badua et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Forecasting fully vaccinated people against COVID-19 and examining future vaccination rate for herd immunity in the US, Asia, Europe, Africa, South America, and the World
Pinar Cihan
APPLIED SOFT COMPUTING (2021)
Design, synthesis and biological evaluation of indanone-chalcone hybrids as potent and selective hCES2A inhibitors
Peng-Chao Huo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
10 years into the resurgence of covalent drugs
Elena De Vita
FUTURE MEDICINAL CHEMISTRY (2021)
The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2
Shagufta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
SARS-CoV-2 M-pro inhibitors with antiviral activity in a transgenic mouse model
Jingxin Qiao et al.
SCIENCE (2021)
COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention
Anshika Sharma et al.
VIRUSES-BASEL (2021)
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations
Chun-Hui Zhang et al.
ACS CENTRAL SCIENCE (2021)
Potential drug targets of SARS-CoV-2: From genomics to therapeutics
Anas Shamsi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Chang Liu et al.
CELL (2021)
The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic
Sarah P. Otto et al.
CURRENT BIOLOGY (2021)
Discovery of naturally occurring inhibitors against SARS-CoV-2 3CLpro from Ginkgo biloba leaves via large-scale screening
Yuan Xiong et al.
FITOTERAPIA (2021)
Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: Inhibition potentials, covalent binding sites and inhibitory mechanisms
Yuan Xiong et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure-Activity Relationship, and X-ray Structural Studies
Arun K. Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
HOW THE CORONAVIRUS INFECTS OUR CELLS
Megan Scudellari
NATURE (2021)
SARS-CoV-2 variants of concern are emerging in India
Jasdeep Singh et al.
NATURE MEDICINE (2021)
Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease
Maya G. Deshmukh et al.
STRUCTURE (2021)
Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
Haixia Su et al.
NATURE COMMUNICATIONS (2021)
Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19)
Ting Wu et al.
FRONTIERS IN MEDICINE (2021)
Current advances in the development of SARS-CoV-2 vaccines
Annoor Awadasseid et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy
Bhupesh Goyal et al.
ACS COMBINATORIAL SCIENCE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
One-Pot Preparation of 9,10-Dihydrophenanthrenes Initiated by Rhodium(III)-Catalyzed C-H Activation and Relay Diels-Alder Reaction
Dingding Gao et al.
ORGANIC LETTERS (2020)
The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020
Yuzhi Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
Chunlong Ma et al.
CELL RESEARCH (2020)
Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease
Qingxin Li et al.
MICROORGANISMS (2020)
Proton-Coupled Conformational Activation of SARS Coronavirus Main Proteases and Opportunity for Designing Small-Molecule Broad-Spectrum Targeted Covalent Inhibitors
Neha Verma et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Inhibition of human carboxylesterases by magnolol: Kinetic analyses and mechanism
Yun-Qing Song et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Peptide chemistry toolbox - Transforming natural peptides into peptide therapeutics
Milos Erak et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
α-Halo carbonyls enable meta selective primary, secondary and tertiary C-H alkylations by ruthenium catalysis
Andrew J. Paterson et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2017)
Modular synthesis of simple cycloruthenated complexes with state-of-the-art performance in p-type DSCs
Felix Brunner et al.
JOURNAL OF MATERIALS CHEMISTRY C (2016)
Discovering severe acute respiratory syndrome coronavirus 3CL protease inhibitors: Virtual screening, surface plasmon resonance, and fluorescence resonance energy transfer assays
Lili Chen et al.
JOURNAL OF BIOMOLECULAR SCREENING (2006)